Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated ...

A 2012 study of patients with low-tumor-burden follicular lymphoma showed that the 4-year freedom from treatment failure rate ...

The reactions to the intracutaneous injections of five antigens and histamine were studied in 114 persons, of whom 33 were patients with Hodgkin's disease, 64 were controls and the remainder had ...

From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...

Dave Coulier says he is celebrating a significant victory in his health journey after being cancer-free post-diagnosis with ...

A young woman who thought her anxiety was due to the recent death of her father was correctly diagnosed with blood cancer by ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for Health and Care Excellence.